These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 21747398)

  • 1. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers.
    Hirvonen J; Goodwin RS; Li CT; Terry GE; Zoghbi SS; Morse C; Pike VW; Volkow ND; Huestis MA; Innis RB
    Mol Psychiatry; 2012 Jun; 17(6):642-9. PubMed ID: 21747398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Cannabinoid CB
    Hirvonen J; Zanotti-Fregonara P; Gorelick DA; Lyoo CH; Rallis-Frutos D; Morse C; Zoghbi SS; Pike VW; Volkow ND; Huestis MA; Innis RB
    Biol Psychiatry; 2018 Nov; 84(10):715-721. PubMed ID: 30121138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain imaging of cannabinoid type I (CB
    Spindle TR; Kuwabara H; Eversole A; Nandi A; Vandrey R; Antoine DG; Umbricht A; Guarda AS; Wong DF; Weerts EM
    Addict Biol; 2021 Nov; 26(6):e13061. PubMed ID: 34028926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography shows elevated cannabinoid CB1 receptor binding in men with alcohol dependence.
    Neumeister A; Normandin MD; Murrough JW; Henry S; Bailey CR; Luckenbaugh DA; Tuit K; Zheng MQ; Galatzer-Levy IR; Sinha R; Carson RE; Potenza MN; Huang Y
    Alcohol Clin Exp Res; 2012 Dec; 36(12):2104-9. PubMed ID: 22551199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based input function modeling for [(18)F]FMPEP-d 2, an inverse agonist radioligand for cannabinoid CB1 receptors: validation in clinical studies.
    Zanotti-Fregonara P; Hirvonen J; Lyoo CH; Zoghbi SS; Rallis-Frutos D; Huestis MA; Morse C; Pike VW; Innis RB
    PLoS One; 2013; 8(4):e60231. PubMed ID: 23577094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids.
    Sim-Selley LJ
    Crit Rev Neurobiol; 2003; 15(2):91-119. PubMed ID: 14977366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users.
    Ceccarini J; Kuepper R; Kemels D; van Os J; Henquet C; Van Laere K
    Addict Biol; 2015 Mar; 20(2):357-67. PubMed ID: 24373053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
    Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
    Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.
    Cooper ZD; Haney M
    Addict Biol; 2008 Jun; 13(2):188-95. PubMed ID: 18279497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex, THC, and hormones: Effects on density and sensitivity of CB
    Farquhar CE; Breivogel CS; Gamage TF; Gay EA; Thomas BF; Craft RM; Wiley JL
    Drug Alcohol Depend; 2019 Jan; 194():20-27. PubMed ID: 30391834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.
    Di Iorio CR; Watkins TJ; Dietrich MS; Cao A; Blackford JU; Rogers B; Ansari MS; Baldwin RM; Li R; Kessler RM; Salomon RM; Benningfield M; Cowan RL
    Arch Gen Psychiatry; 2012 Apr; 69(4):399-409. PubMed ID: 22147810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography.
    Hirvonen J; Zanotti-Fregonara P; Umhau JC; George DT; Rallis-Frutos D; Lyoo CH; Li CT; Hines CS; Sun H; Terry GE; Morse C; Zoghbi SS; Pike VW; Innis RB; Heilig M
    Mol Psychiatry; 2013 Aug; 18(8):916-21. PubMed ID: 22776901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of the cannabinoid CB₁ receptor PET ligand ortholog, [³H]MePPEP.
    Suter TM; Chesterfield AK; Bao C; Schaus JM; Krushinski JH; Statnick MA; Felder CC
    Eur J Pharmacol; 2010 Dec; 649(1-3):44-50. PubMed ID: 20851117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous cannabinoid withdrawal produces a differential time-related responsiveness in cannabinoid CB1 receptor gene expression in the mouse brain.
    Oliva JM; Ortiz S; Palomo T; Manzanares J
    J Psychopharmacol; 2004 Mar; 18(1):59-65. PubMed ID: 15107186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence.
    Cooper ZD; Haney M
    Int Rev Psychiatry; 2009 Apr; 21(2):104-12. PubMed ID: 19367504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia.
    Rais M; van Haren NE; Cahn W; Schnack HG; Lepage C; Collins L; Evans AC; Hulshoff Pol HE; Kahn RS
    Eur Neuropsychopharmacol; 2010 Dec; 20(12):855-65. PubMed ID: 20863671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents.
    Álvaro-Bartolomé M; García-Sevilla JA
    Neuroscience; 2013 Sep; 247():294-308. PubMed ID: 23727505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [¹¹C]MePPEP.
    Riaño Barros DA; McGinnity CJ; Rosso L; Heckemann RA; Howes OD; Brooks DJ; Duncan JS; Turkheimer FE; Koepp MJ; Hammers A
    Neuroimage; 2014 Aug; 97():151-62. PubMed ID: 24736184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia.
    Jenko KJ; Hirvonen J; Henter ID; Anderson KB; Zoghbi SS; Hyde TM; Deep-Soboslay A; Innis RB; Kleinman JE
    Schizophr Res; 2012 Nov; 141(2-3):185-8. PubMed ID: 22910406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid Type 1 Receptor (CB1) Ligands with Therapeutic Potential for Withdrawal Syndrome in Chemical Dependents of Cannabis sativa.
    Ferreira JV; Chaves GA; Marino BLB; Sousa KPA; Souza LR; Brito MFB; Teixeira HRC; da Silva CHTP; Santos CBR; Hage-Melim LIS
    ChemMedChem; 2017 Aug; 12(16):1408-1416. PubMed ID: 28417566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.